Sandu Pharma 41st AGM: All 8 resolutions passed including dividend declaration

Sandu Pharma held its 41st AGM on 11 Sep 2026 via video conferencing with 54 of 10,523 shareholders attending. All 8 resolutions passed with over 99.99% support. Items include: FY26 audited financials adopted, dividend declared, Jayashree Sandu reappointed as director, Dave and Dave appointed as statutory auditors for 5 years, cost auditor remuneration ratified, material related party transaction with Sandu Brothers approved, Balram Viswanathan redesignated as Chairman and Managing Director, and Dr Neeti Kapre appointed as independent director.